Trichomonas vaginalis: treatment questions and challenges

Por Secor, W Evan
Publicado no Expert Rev Anti Infect Ther (2012)

Early lessons from schistosomiasis mass drug administration programs

Por Secor, W. Evan
Publicado no F1000Res (2015)

Toward Mass Drug Administration Stopping Criteria for Schistosoma mansoni Control Programs

Por Secor, W. Evan
Publicado no Am J Trop Med Hyg (2019)

Schistosomiasis

Por Secor, W. Evan., Colley, Daniel G.
Publicado em c200

Differential Vβ T-Cell Receptor Usage during Chronic Experimental Schistosomiasis Corresponds with Distinct Pathological Presentations

Por Secor, W. Evan, Freeman, George L.
Publicado em 2001

A Schistosomiasis Research Agenda

Por Colley, Daniel G., Secor, W. Evan
Publicado em 2007

Something old, something new: is praziquantel enough for schistosomiasis control?

Por Secor, W Evan, Montgomery, Susan P
Publicado no Future Med Chem (2015)

When Should the Emphasis on Schistosomiasis Control Move to Elimination?

Por Secor, W. Evan, Colley, Daniel G.
Publicado no Trop Med Infect Dis (2018)

Trichomonas vaginalis-Induced Epithelial Monolayer Disruption and Human Immunodeficiency Virus Type 1 (HIV-1) Replication: Implications for the Sexual Transmission of HIV-1

Por Guenthner, Patricia C., Secor, W. Evan, Dezzutti, Charlene S.
Publicado em 2005

Infection and treatment immunizations for successful parasite vaccines

Por Mutapi, Francisca, Billingsley, Peter F., Secor, W. Evan
Publicado em 2013

In Vitro Metronidazole and Tinidazole Activities against Metronidazole- Resistant Strains of Trichomonas vaginalis

Por Crowell, Andrea L., Sanders-Lewis, Kolby A., Secor, W. Evan
Publicado em 2003

Trichomonas vaginalis Contact-Dependent Cytolysis of Epithelial Cells

Por Lustig, Gila, Ryan, Christopher M., Secor, W. Evan, Johnson, Patricia J.
Publicado em 2013

Neglected Parasitic Infections in the United States: Trichomoniasis

Por Secor, W. Evan, Meites, Elissa, Starr, Michelle C., Workowski, Kimberly A.
Publicado em 2014

Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis

Por Secor, Virginia H., Secor, W. Evan, Gutekunst, Claire-Anne, Brown, Melissa A.
Publicado em 2000

Schistosoma mansoni Infection Impairs Antimalaria Treatment and Immune Responses of Rhesus Macaques Infected with Mosquito-Borne Plasmodium coatneyi

Por Semenya, Amma A., Sullivan, JoAnn S., Barnwell, John W., Secor, W. Evan
Publicado em 2012

Human schistosomiasis

Por Colley, Daniel G, Bustinduy, Amaya L, Secor, W Evan, King, Charles H
Publicado no Lancet (2014)

Activities of Dicationic Compounds against Trichomonas vaginalis

Por Crowell, Andrea L., Stephens, Chad E., Kumar, Arvind, Boykin, David W., Secor, W. Evan
Publicado em 2004

Idiotypes Expressed Early in Experimental Schistosoma mansoni Infections Predict Clinical Outcomes of Chronic Disease

Por Montesano, M. Angela, Colley, Daniel G., Willard, Margaret T., Freeman, George L., Secor, W. Evan
Publicado em 2002

Neonatal Idiotypic Exposure Alters Subsequent Cytokine, Pathology, and Survival Patterns in Experimental Schistosoma mansoni Infections

Por Angela Montesano, M., Colley, Daniel G., Eloi-Santos, Silvana, Freeman, George L., Secor, W. Evan
Publicado em 1999

Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial Schistosoma mansoni Infection Preva...

Por Secor, W. Evan, Wiegand, Ryan E., Montgomery, Susan P., Karanja, Diana M. S., Odiere, Maurice R.
Publicado no Am J Trop Med Hyg (2020)